1. Nasal drug Delivery
market overview
Ishan Shukla

2. Global Respiratory Market Overview
USA Increases
overall

3. Respiratory Market Growth 2005-2014

4. Branded Respiratory Revenue Growth

5. Asthma /COPD Market Share
Region wise Therapeutic segment wise
1. Inhaled corticosteroids+
long acting beta-2 agonists :
35%
2. Leukotrine antagonists :
15%
3. Single inhaled
corticosteroids: 35%

6. Basic mechanism of DPIs

7. Basic mechanism of MDIs

8. Devices are the big differentiator
Devices are the big differentiator
Branded combination DPIs is the biggest sector in the
respiratory market with over USD10bn sales, followed by
MDIs.
However, by volume HFA midis are replacing
CFC inhalers. The development of these products requires
integrated development of both formulation and the device.

9. DPI Vs. MDI

10. Generic Inhalers in US Market

12. KEY OPPERTUNITIES FOR MNCs

13. Glaxo Smith Kline

14. AstraZeneca

15. Boehringer Ingelheim

16. Schering plough/
Teva/Sunovion

17. TEVA Respiratory Pipeline

18. Therapeutic Segment wise Market share

19. Therapeutic segment wise

20. Therapeutic segment wise

22. Thank You